Stifel Financial’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.78M Buy
28,832
+634
+2% +$63.4K ﹤0.01% 1722
2025
Q4
$2.74M Sell
28,198
-568
-2% -$48.7K ﹤0.01% 1716
2025
Q3
$2.05M Sell
28,766
-451
-2% -$30.1K ﹤0.01% 1898
2025
Q2
$1.75M Sell
29,217
-669
-2% -$36.7K ﹤0.01% 1945
2025
Q1
$1.57M Buy
29,886
+3,591
+14% +$202K ﹤0.01% 1934
2024
Q4
$1.45M Buy
26,295
+1,867
+8% +$98.2K ﹤0.01% 2007
2024
Q3
$1.23M Buy
24,428
+2,174
+10% +$100K ﹤0.01% 2090
2024
Q2
$978K Buy
22,254
+1,642
+8% +$69.8K ﹤0.01% 2179
2024
Q1
$907K Buy
+20,612
New +$911K ﹤0.01% 2239
2016
Q2
Sell
-13,756
Closed -$264K 2538
2016
Q1
$264K Buy
13,756
+4,151
+43% +$79.4K ﹤0.01% 1880
2015
Q4
$269K Sell
9,605
-12,934
-57% -$366K ﹤0.01% 1969
2015
Q3
$549K Buy
22,539
+6,732
+43% +$161K ﹤0.01% 1497
2015
Q2
$368K Sell
15,807
-1,084
-6% -$19.8K ﹤0.01% 1849
2015
Q1
$257K Buy
16,891
+3,665
+28% +$54.1K ﹤0.01% 1985
2014
Q4
$171K Buy
+13,226
New +$114K ﹤0.01% 2125

Other funds holding IRMD

Stifel Financial's IRMD Position: Q1 2026 in Review

Stifel Financial increased its iRadimed (IRMD) stake by 2.2% in Q1 2026, buying an estimated $63.4K and bringing the position to 28,832 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1722.

Stifel Financial first reported a position in IRMD in Q4 2014 and has held it in 15 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Stifel Financial held 28,832 shares of iRadimed worth $2.78M as of Q1 2026.
  • Stifel Financial bought 634 iRadimed shares in Q1 2026, an estimated $63.4K.
  • iRadimed made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #1722 holding.
  • Stifel Financial first reported a position in iRadimed in Q4 2014 and has held it in 15 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.